Re-introducing an 'old' antibiotic may help fight multi-drug resistant bacteria

antibiotics
Credit: CC0 Public Domain

A new study indicates that the drug fosfomycin may be effective for treating multidrug-resistant bacterial infections. In most European countries, the oral formulation is only approved as a 3 gram single dose for the treatment of uncomplicated cystitis; however the Pharmacology Research & Perspectives study found that a dosing regimen of 6-12 grams per day divided in 3 doses is required for the treatment of systemic multi-drug-resistant bacterial infections.

Fosfomycin—an 'old' antibiotic that was developed more than 40 years ago—is a that inhibits the early stages of the synthesis.

"Importantly, we show that there is a viable alternative to the lengthy and thus costly development of new antibiotics. The often scattered knowledge in literature and in the clinic is waiting to be combined and can be used immediately in a confirmatory clinical trial," said senior author Dr. Jasper Stevens, of the University Medical Center Groningen, in The Netherlands.


Explore further

Supercharged antibiotics could turn tide against superbugs

More information: Natalia V. Ortiz Zacarías et al, Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens, Pharmacology Research & Perspectives (2018). DOI: 10.1002/prp2.378
Provided by Wiley
Citation: Re-introducing an 'old' antibiotic may help fight multi-drug resistant bacteria (2018, February 7) retrieved 22 February 2019 from https://medicalxpress.com/news/2018-02-re-introducing-antibiotic-multi-drug-resistant-bacteria.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more